3382 Results

People

  1. Hudis
    Hudis
  2. Soslow
    Soslow
  3. Gonen
    Gonen
  4. Ladanyi
    Ladanyi
  5. Motzer
    Motzer
  6. Rusch
    Rusch
  7. Patil
    Patil
  8. Barakat
    Barakat
  9. Kris
    Kris
  10. Scher
    Scher

Groups

  1. Department of Medicine (1176)
  2. Surgery (803)
  3. GSK Faculty (796)
  4. Solid Tumor Oncology Division (659)
  5. Sloan Kettering Institute Faculty (606)
  6. Survivorship Research (542)
  7. Department of Pathology and Laboratory Medicine (408)
  8. Center for Hematologic Malignancies (395)
  9. Epidemiology and Biostatistics (369)
  10. Hematologic Malignancies, Division of (342)
  1. "2011"
Formats
  1. Journal Article (2141)
  2. Meeting Abstract (988)
  3. Book Section (224)
  4. Conference Paper (18)
  5. Book Whole (11)
Groups
  1. Department of Medicine (1176)
  2. Surgery (803)
  3. GSK Faculty (796)
  4. Solid Tumor Oncology Division (659)
  5. Sloan Kettering Institute Faculty (606)
  6. Survivorship Research (542)

More Groups

People
  1. Robert Soslow (64)
  2. Clifford Hudis (60)
  3. Mithat Gonen (54)
  4. Marc Ladanyi (52)
  5. Robert Motzer (52)
  6. Valerie Rusch (47)

More People

Years
  1. 2011 (3382)
Publications
  1. Journal of Clinical Oncology (319)
  2. Blood (147)
  3. Cancer Research (122)
  4. International Journal of Radiation Oncology, Biology, Physics (104)
  5. Modern Pathology (70)
  6. Laboratory Investigation (65)

More Publications

Publishers
  1. Elsevier Inc. (450)
  2. American Society of Clinical Oncology (327)
  3. Springer (231)
  4. American Association for Cancer Research (180)
  5. Nature Publishing Group (157)
  6. Wiley Blackwell (154)

More Publishers

Results (3382)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Addition of AEG35156 XIAP antisense oligonucleotide in reinduction chemotherapy does not improve remission rates in patients with primary refractory acute myeloid leukemia in a randomized phase II study
    Journal Article

    Schimmer, A. D.; Herr, W.; Hanel, M.; Borthakur, G.; Frankel, A.; Horst, H. A.; Martin, S.; Kassis, J.; Desjardins, P.; Seiter, K.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2011)

    Fulltext@MSK | Save
  • Targeting the PI3K/AKT/mTOR pathway in non-Hodgkin's lymphoma: Results, biology, and development strategies
    Journal Article

    Schatz, J. H.
    Current Oncology Reports (2011)

    Fulltext@MSK | Save
  • Combined anti-angiogenesis and radioimmunotherapy for neuroblastoma: Results of a phase I study
    Meeting Abstract

    Modak, S.; Kushner, B.; Kramer, K.; Cheung, N. K.
    Pediatric Blood and Cancer (2011)

    Fulltext@MSK | Save
  • Micrornas 99b, 181a and 181b are induced during human embryonic stem cell differentiation to vascular endothelial cells and can enhance differentiation capacity upon differentiation
    Journal Article

    Kane, N. M.; Howard, L.; Khanin, R.; McClure, J.; Breen, C.; Milligan, G.; Baker, A. H.
    Heart (2011)

    Fulltext@MSK | Save
  • Longitudinal changes in health status of the childhood cancer survivor cohort
    Meeting Abstract

    Hudson, M.; Oeffinger, K.; Nathan, P.; Mertens, A.; Castellino, S.; Mulrooney, D.; Gurneys, J.; Armstrong, G.; Leisenringth, W.; Robison, L.; more...
    Pediatric Blood and Cancer (2011)

    Fulltext@MSK | Save
  • Use of inhibin B and follicle stimulating hormone (FSH) for identification of male survivors of childhood cancer with azoospermia. A report from the St. Jude Lifetime Cohort Study (SJLIFE)
    Meeting Abstract

    Green, D.; Zhu, L.; Sklar, C.; Klosky's, J.; Ke, R.; Kutteh, W.; Spunt, S.; Metzger, M.; Navid, F.; Srivastava, D. K.; more...
    Pediatric Blood and Cancer (2011)

    Fulltext@MSK | Save
  • Sequence-specific (1)H, (13)C and (15)N assignments of the phosphoesterase (PE) domain of Pseudomonas aeruginosa DNA ligase D (LigD)
    Journal Article

    Dutta, K.; Natarajan, A.; Nair, P. A.; Shuman, S.; Ghose, R.
    Biomolecular NMR Assignments (2011)

    Fulltext@MSK | Save
  • Phase 2 study of safety and efficacy of nimotuzumab (theracim (R)) in pediatric patients with recurrent diffuse intrinsic pontine glioma (DIPG)
    Meeting Abstract

    Bartels, U.; Wolff, J.; Gore, L.; Dunkel, I.; Allen, J.; Goldman, S.; Yalon, M.; Packer, R.; Korones, D.; Smith, A.; more...
    Pediatric Blood and Cancer (2011)

    Fulltext@MSK | Save
  • Dermatologic side effects associated with the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886)
    Journal Article

    Balagula, Y.; Huston, K. B.; Busam, K. J.; Lacouture, M. E.; Chapman, P. B.; Myskowski, P. L.
    Investigational New Drugs (2011)

    Fulltext@MSK | Save
  • Phase I dose-escalation trial of clofarabine (Clo) followed by escalating soses of fractionated cyclophosphamide (Cy) in children with relapsed or refractory acute leukemias
    Meeting Abstract

    Abd Elmonelm, A.; Gore, L.; Bolkan, J.; Cooper, T.; Narendran, A.; Rolla, K.; Barfchin, S.; Scott, T.; Arceci, R.
    Pediatric Blood and Cancer (2011)

    Fulltext@MSK | Save